Appetite-suppressing drugs like Ozempic don’t just shrink waistlines — they cut food spending, according to the Cornell Chronicle. A new Cornell study links GLP-1 drug use to sharp drops in grocery and restaurant purchases.
Within six months of starting the medication, households spent about 5% less on groceries and roughly 8% less at fast-food and coffee shops. Higher-income households saw even bigger declines. The biggest cuts hit snacks, sweets and other ultra-processed foods.
When users stopped taking the drugs, spending bounced back — often with less healthy choices. Researchers say the shift could reshape food markets as GLP-1 use keeps rising.

